跳至主要内容
临床试验/NCT03186079
NCT03186079已完成早期 1 期

Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Functional Constipation: a Double Blind, Randomized and Placebo-controlled Trial

Shengjing Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年5月1日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
入组人数
200
试验地点
1
主要终点
Baseline of constipation score in the beginning of treatment

研究概览

简要总结

Constipation is the most common complaint in childhood gastrointestinal disease,affecting an estimated 20% of the global children.The treatment strategies consist of diet control,behavioural intervention and oral and sometimes rectal laxatives. Given higher success rate and fewer side effects,the laxative PEG3350 has been considered the first choice in childhood constipation.However, effectiveness of PEG 3350 laxative is not lasting, additional treatment interventions are still necessary.With an unsatisfactory response to current treatments, many patients seek help from Chinese Herbal Medicine.In view of the traditional theory, childhood constipation is derived from weakness of gastric and splenic function.The functional weakness is characterized by food stagnation and further pathological heat accumulation in the gastrointestine. The food stagnation can slow the gastrointestinal motility while heat causes constipation by drying the intestines and their content. Therefore, the therapeutic principles and practices for childhood constipation must focus on the pathophysiological basis accordingly. In the documented traditional medicine dictionary(Pi Wei Lun), Xiaojidaozhi Decoction is well described in improving the gastric and splenic function, eliminating food stagnation and removing pathological heat accumulation, and it has always been used in treatment of constipation throughout Asia since the first description in Pi Wei Lun in 1249. It comprises twelve herbs. Through the combined action of these herbs, Xiaojidaozhi Decoction can increase fluid in the intestines and facilitate the gastrointestinal motility, relieving the symptoms of constipation. Despite of the long history of successful use of Xiaojidaozhi Decoction in childhood constipation, a large randomized placebo-controlled trial is still not available.The aim of this study was to explore the clinical efficacy and safety of Chinese herbal medicine Xiaojidaozhi Decoction in the treatment of childhood constipation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
4 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of childhood constipation
  • Criteria of constipation meets the Rome IV criteria(H3a)
  • Must be able to swallow capsules

排除标准

  • Digestive tract diseases
  • Neurologic diseases
  • Endocrine diseases
  • Metabolic diseases
  • Gastrointestinal surgery
  • Using drugs which can take impact on bowl motility

研究组 & 干预措施

Xiaojidaozhi Decoction

Active Comparator

Xiaojidaozhi Decoction and Fiberform and Toilet training are used for treatment of childhood Constipation

干预措施: Xiaojidaozhi Decoction (Drug)

Xiaojidaozhi Decoction

Active Comparator

Xiaojidaozhi Decoction and Fiberform and Toilet training are used for treatment of childhood Constipation

干预措施: Fiberform (Drug)

Xiaojidaozhi Decoction

Active Comparator

Xiaojidaozhi Decoction and Fiberform and Toilet training are used for treatment of childhood Constipation

干预措施: Toilet training (Behavioral)

non-Xiaojidaozhi Decoction

Placebo Comparator

Placebo and Fiberform and Toilet training are used for treatment of childhood Constipation

干预措施: Placebo (Drug)

non-Xiaojidaozhi Decoction

Placebo Comparator

Placebo and Fiberform and Toilet training are used for treatment of childhood Constipation

干预措施: Fiberform (Drug)

non-Xiaojidaozhi Decoction

Placebo Comparator

Placebo and Fiberform and Toilet training are used for treatment of childhood Constipation

干预措施: Toilet training (Behavioral)

结局指标

主要结局

Baseline of constipation score in the beginning of treatment

时间窗: beginning of treatment(baseline)

Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence

Change of constipation score from the baseline in the end of follow-up

时间窗: week 20(end of follow-up)

Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence

Percentage of overall efficacy

时间窗: week 20(end of follow-up)

Efficacy is ranked as cured, improved, same/worse

Change of constipation score from the baseline in the end of treatment

时间窗: week 8(end of treatment)

Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence

次要结局

  • Incidence of Treatment-Emergent Adverse Events(Within week 20(end of follow-up))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shucheng Zhang

Professor

Shengjing Hospital

研究点 (1)

Loading locations...

相似试验